Runway, the first DTC travel telehealth company that provides travelers access to affordable and convenient prescription medications to treat the most common travel ailments, launched today. Revolutionizing the $12 billion travel health industry, the platform is available in all 50 states and is poised to replace the often-expensive, convoluted and antiquated travel clinics and primary care physician visits individuals typically need to schedule before domestic, at sea and international depar

Fractyl Health, an organ-editing metabolic therapeutics company focused on pioneering a new approach to the treatment of type 2 diabetes (T2D), announced today new data from its Revita-1 and Revita-2 studies. Prior publications from these open-label and sham-controlled studies have shown improvements in glycemic control and weight in subjects with inadequately controlled type 2 diabetes. New data presented at this week’s Digestive Disease Week® (DDW) 2022 build on this earlier evide

Exergen Corporation, a world leader in industrial and medical non-invasive temperature technology, launched the made for India, TAT-2000 Temporal Artery Thermometer at the Medical Fair in Mumbai from the 20th to the 22nd of May, 2022. From providing temperature sensors for NASA and other industries like robotics, automotive and printing, to creating one of the most accepted temperature measuring devices for babies and elders. Exergen creates non-invasive temperature measurement devices provid

InterSystems, a provider of next-generation solutions for enterprise digital transformation to help customers solve the most critical data challenges, has announced the next phase of its partnership with the Rhodes Group to improve Hepatitis C treatments in the U.S. state of New Mexico with innovative analytics that aggregate, sort and present a patient’s status with one click. As part of the initiative, the Rhodes Group leveraged InterSystems IRIS for Health™ to create unified vi

Big Health has become the first digital therapeutics company to receive guidance from the National Institute for Health and Care Excellence (NICE), which has recommended Sleepio as a cost-saving option for treating insomnia in a move that heralds a new era in digital medicine. The NICE guidance states that Sleepio, Big Health’s digital therapeutic for insomnia, is a safe and effective treatment for people who would otherwise only have access to the current standard of care, wh

Amwell®, a digital care delivery leader, today announced the continued expansion of its ecosystem with the launch of the Amwell Comprehensive Behavioral Health Program, an evidence-based, comprehensive and scalable behavioral health solution that can be tailored to meet specific population needs across the full spectrum of care. Designed to address the growing mental health crisis, the Amwell program enables payers and providers to deliver integrated solutions including virtual therapy an

Prosperdtx™, a leader in the emerging field of digital therapeutics providing predictive and personalized continuity of care for cancer patients, announced today that it will be collaborating with health equity researchers from the Office of Minority Health & Health Disparities Research at the Georgetown University Lombardi Comprehensive Cancer Center and Seqster, the leader in patient-centric healthcare technology, to empower patients with real-time access to their health data enab

XACT Robotics®, developer of the world’s first and only comprehensive robotic system for interventional radiology, announced today that the XACT ACE® Robotic System received US Food and Drug Administration (FDA) clearance for a modification to its cleared XACT ACE® Robotic System designed to support robotic insertion and steering of ablation probes during ablation clinical procedures. This clearance expands the company’s already broad indication for CT-guided percutane

BD (Becton, Dickinson and Company), a leading global medical technology company, and Mitsubishi Gas Chemical Company, Inc. (MGC), a R&D-oriented chemical manufacturer based in Tokyo, Japan, today announced that they have entered into an agreement to investigate further development of OXYCAPT™ - an innovation from MGC that integrates the best of plastic and glass for plastic syringes. Together, the companies will look into applying the OXYCAPT™ technology to the next

Ortek Therapeutics, Inc., a leader in developing and commercializing novel oral care technologies, today announced that the Brazilian Patent and Trademark Office has issued a patent covering the Ortek-ECD®, a revolutionary electronic cavity detection device that can detect tooth decay often missed by X-rays. With the addition of this newly issued patent in Brazil, the ECD is now covered by 20 issued patents in major global markets with patents now issued in: the United States, A